EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
51 hedge funds and large institutions have $6.08M invested in Eiger BioPharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.07M | |
| 2 | +$47K | |
| 3 | +$21.4K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$12.2K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$7.04K |
Top Sellers
| 1 | -$737K | |
| 2 | -$147K | |
| 3 | -$114K | |
| 4 |
JP Morgan Chase
New York
|
-$90.7K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$67K |